News

Alvesco (ciclesonide) is an inhaled corticosteroid with novel release and distribution properties that result in lung-targeted anti-inflammatory effects. The product is currently approved in 35 countries worldwide for

King is set to pay up to $110 million for rights to current and future new drug applications held by Arrow regarding novel formulations of Altace. The agreements

Scavidin was used to target and concentrate intravenous doses of as little as one-tenth the conventional levels of the radioisotope Yttrium(90) in one model, and the chemotherapy drug

The project, which is funded by the German Federal Ministry of Education and Research, is focusing on the properties of nanoparticles to ensure that they pose no risk

The study in colorectal cancer is being conducted to determine whether survival is prolonged in patients with metastatic colorectal cancer treated with Erbitux in combination with the chemotherapeutic

Such adverse events have been reported in cancer patients receiving systemic administration of a pan-VEGF inhibitor, with a greater incidence in patients over 65 years of age. “The

The Australian National University (ANU) was one of the various academic institutions to benefit from the funding. Researchers at the ANU College of Medicine and Health Sciences have

The multicenter study will compare Nexavar when co-administered with the chemotherapeutic agents versus the chemotherapeutic agents alone. The study, which is expected to enroll approximately 900 patients, will

The programs aim to develop and bring to market a variety of new and promising nutritional products. Investors in this round of financing include both new and existing